Investigating a stock’s 52-week price history, covering the range of low and high prices, can provide significant information about its present state and future potential. Ultragenyx Pharmaceutical Inc’s current trading price is -20.27% away from its 52-week high, while its distance from the 52-week low is 30.01%. The stock’s price range during this period has varied between $37.02 and $60.37. The company, active in the Healthcare sector, saw a trading volume of around 0.3 million for the day, considerably lower average daily volume of 0.71 million observed over the last three months.
Ultragenyx Pharmaceutical Inc’s stock market performance has been consistent. The 1-year high for the company’s stock was recorded at $60.37 on 09/16/24, with the lowest value being $37.02 on 06/18/24.
How Financial Performance Impacts Market Capitalization
Ultragenyx Pharmaceutical Inc (RARE) has experienced a quarterly decline of -15.50% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 4.44B and boasts a workforce of 1276 employees.
The Role of Moving Averages and Trading Volume in Technical Analysis
Based on Barchart.com data, the company’s moving average over the 100-day period was 51.83, with a change in price of +5.88. Similarly, Ultragenyx Pharmaceutical Inc recorded 729,499 in trading volume during the last 100 days, posting a change of +13.92%.
How RARE’s Debt-to-Equity Ratio Affects Financial Health
A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for RARE stands at 2.63. Similarly, the long-term debt-to-equity ratio is also 2.46.
RARE Stock Stochastic Average
As of today, the raw stochastic average of Ultragenyx Pharmaceutical Inc over the past 50 days is 30.19%. This is a decrease compared to the raw stochastic average of the last 20 days, which was recorded at 48.80%. Additionally, the Stochastic %K and %D values for the company were 43.10% and 38.10%, respectively, over the past 20 days.
RARE Stock Price Performance Analysis
Depending on how one views it, the stock price performance for the year has been a mixed bag, resulting in either an optimistic or pessimistic outlook. The metric has seen a significant gain of 0.65% since the start of this calendar year. Looking back over the last six months, we can see a weaker performance of 24.53%. Over the past 30 days, the price of RARE has leaped by -8.84%. And in the last five days, it has surged by 3.73%.
